# Compare Sequential and Quadruple Therapy for the Eradication of Helicobacter Pylori in Korea

> **NCT02159976** · NA · COMPLETED · sponsor: **Seoul National University Bundang Hospital** · enrollment: 390 (actual)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Pantoprazole
- **DRUG:** Amoxicillin
- **DRUG:** Clarithromycin
- **DRUG:** Metronidazole
- **DRUG:** Tetracycline
- **DRUG:** Bismuth

## Key facts

- **NCT ID:** NCT02159976
- **Lead sponsor:** Seoul National University Bundang Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2015-05
- **Final completion:** 2016-04
- **Target enrollment:** 390 (ACTUAL)
- **Last updated:** 2019-05-13

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02159976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02159976, "Compare Sequential and Quadruple Therapy for the Eradication of Helicobacter Pylori in Korea". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02159976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*